View Older Stories View More Recent Stories

Jan 3, 2018 09:00AM New FDA MR-Conditional Labeling Approvals Further Expand Abbott's Portfolio of MRI-Ready Devices
Jan 2, 2018 09:00AM Abbott Launches Alinity™ h-series Integrated Hematology System, Combining Speed, Accuracy and Seamless Integration
Dec 18, 2017 09:00AM Abbott Hosts Conference Call for Fourth-Quarter Earnings
Dec 15, 2017 10:17AM Abbott Raising Quarterly Dividend for 46th Straight Year
Dec 4, 2017 09:00AM Abbott to Present at J.P. Morgan Healthcare Conference
Nov 6, 2017 08:07AM Abbott (ABT) Says its MitraClip Approved as First Transcatheter Mitral Valve Repair Device in Japan
Nov 6, 2017 08:00AM Abbott's MitraClip Approved as First Transcatheter Mitral Valve Repair Device in Japan
Oct 31, 2017 09:03AM Abbott (ABT) Reports FDA Clearance for its Alinity ci-series Next-generation Diagnostic Systems
Oct 31, 2017 09:00AM Abbott Announces FDA Clearance for its Alinity™ ci-series Next-generation Diagnostic Systems
Oct 30, 2017 01:20PM Analysis of Landmark Study Showed Patients Treated for Left-Main Coronary Artery Disease with XIENCE Stent Felt Better Faster and Had Similar Long-Term Outcomes to Open-Heart Surgery
Oct 30, 2017 07:00AM Abbott Introduces Next Generation of Most Widely Used Heart Stent for People with Coronary Artery Disease in Europe[1]
Oct 23, 2017 09:00AM Abbott Launches the First and Only Smartphone Compatible Insertable Cardiac Monitor in the U.S.
Oct 19, 2017 02:59PM A Great Place to Do Great Things: Developing Game-Changing Technology at Abbott
Oct 18, 2017 07:45AM Abbott Reports Third-Quarter 2017 Results
Oct 16, 2017 09:00AM Patients Battling Complex Regional Pain Syndrome Find a Host of New Benefits in Abbott's Proclaim™ DRG System
Oct 4, 2017 08:00AM Abbott Completes Cash Tender Offer for Series B Convertible Perpetual Preferred Stock of Alere Inc.
Oct 2, 2017 08:00AM Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.
Sep 29, 2017 09:22AM Abbott (ABT) Se to Close Alere (ALR) Takeover on October 3
Sep 29, 2017 09:20AM Abbott Acquisition of Alere Set to Close on Tuesday, October 3, 2017
Sep 27, 2017 05:42PM No More Routine Finger Sticks(1) for Americans with Diabetes: Abbott′s FreeStyle® Libre Approved in the U.S.
Sep 22, 2017 08:01AM Abbott (ABT) Reports FDA Approval for MRI-Compatibility for Ellipse ICD
Sep 22, 2017 08:00AM Abbott Secures FDA Approval for MRI-Compatibility for the Company's Ellipse™ ICD
Sep 20, 2017 09:00AM Abbott Hosts Conference Call for Third-Quarter Earnings
Sep 19, 2017 06:35AM Absolute to Present at the Dougherty & Company Institutional Investor Conference
Sep 18, 2017 08:00AM Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.
Sep 14, 2017 12:28PM Abbott Declares 375th Consecutive Quarterly Dividend
Sep 13, 2017 07:00AM FreeStyle® Libre Flash Glucose Monitoring Technology Gains Reimbursement Approval from the United Kingdom's National Health Service
Sep 11, 2017 08:30AM Absolute to Present at the Dougherty & Company Institutional Investor Conference
Sep 7, 2017 11:49AM Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index (DJSI)
Sep 7, 2017 08:45AM Absolute Announces Approval of Normal Course Issuer Bid
Sep 1, 2017 08:00AM Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.
Aug 31, 2017 09:00AM Revolutionary Glucose Monitoring Technology FreeStyle® Libre Now Reimbursed Across Japan
Aug 30, 2017 11:57AM Abbott (ABT) Initiates Study of AMPLATZER Device to Correct Congenital Heart Defect in Newborns
Aug 30, 2017 11:55AM Abbott initiates ground-breaking U.S. pivotal study of AMPLATZER device to correct common congenital heart defect in newborns
Aug 29, 2017 03:02PM Abbott and the Abbott Fund Donate $1 Million to Support Hurricane Harvey Relief Efforts
Aug 28, 2017 09:05AM Abbott (ABT) Reports FDA Approval for Full MagLev HeartMate 3 LVAD
Aug 28, 2017 09:00AM Abbott Introduces HeartMate 3 Left Ventricular Assist System - the Latest Milestone In Therapy For Advanced Heart Failure Patients
Aug 14, 2017 08:00AM Abbott Announces Extension of Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.
Aug 10, 2017 09:00AM The Cost of Malnutrition: Study Shows Nutrition Program Could Save Hospitals up to $3,800 per Patient
Jul 20, 2017 07:45AM Abbott Reports Second-Quarter 2017 Results
Jul 17, 2017 08:17AM Abbott Commences Cash Tender Offer for All Outstanding Shares of Series B Convertible Perpetual Preferred Stock of Alere Inc.
Jul 13, 2017 07:32AM Abbott (ABT), Bigfoot Biomedical Enter Pact to Develop Breakthrough Diabetes Technologies
Jul 13, 2017 07:30AM Abbott and Bigfoot Biomedical Announce Collaboration to Develop Breakthrough Diabetes Technologies
Jun 29, 2017 01:32PM Abbott Secures Health Canada License for FreeStyle® Libre System for People with Diabetes
Jun 21, 2017 09:00AM Abbott Hosts Conference Call for Second-Quarter Earnings
Jun 9, 2017 10:15AM Abbott Declares 374th Consecutive Quarterly Dividend
May 9, 2017 09:01AM Abbott (ABT) Receives CE Mark for TactiCath Contact Force Ablation Catheter, Sensor Enabled
May 9, 2017 09:00AM Abbott Announces CE Mark for TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™
May 8, 2017 09:00AM Abbott Announces CE Mark and First Use of the World's First Smartphone Compatible Insertable Cardiac Monitor
May 8, 2017 06:00AM Abbott Announces National Reimbursement for FreeStyle® Libre in France, Providing Access to Revolutionary Technology for People with Diabetes
View More Recent Stories View Older Stories